glp 1 resistant food research Frontiers oat beta glucan The GLP-1 effect: Reformulating for
Description
[13] A 2021 meta-analysis found that over 1 year of clinical use, tirzepatide was superior to dulaglutide, semaglutide, insulin degludec, and insulin glargine in improving blood sugar control and reducing body weight
The most commonly discussed options include: Ozempic / semaglutide Wegovy / semaglutide Mounjaro / tirzepatide liraglutide exenatide Tirzepatide may be discussed differently because it acts on both GLP-1 and GIP receptors , making it mechanistically distinct
Additional Benefits of GLP-1 RA Cardiovascular outcomes trials have demonstrated additional benefits of this medication class in T2DM patients, most notably a reduction in cardiovascular events for patients with established atherosclerotic cardiovascular disease (ASCVD) and those at higher ASCVD risk
That's where LMNT may have an advantage
In contrast, a microdose might start at just 0.05 mg to 0.25 mg weeklyoften less than one-tenth the full dose
Funding This paper was supported by the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre
